01 — Genomic instability
Primary hallmark ("damage") according to López-Otín et al., Cell 2023 (doi:10.1016/j.cell.2022.11.001).
1. Definition
Accumulation, over a lifetime, of lesions and alterations of nuclear and mitochondrial DNA (breaks, point mutations, rearrangements, aneuploidies, retrotransposon insertions) that exceed the repair capacities of the cell. It meets the three criteria of a hallmark: it increases with age, its experimental aggravation accelerates aging, and its reduction slows it down, at least in animals (López-Otín 2013, doi:10.1016/j.cell.2013.05.039; Schumacher 2021, doi:10.1038/s41586-021-03307-7).
In plain terms: DNA is the "instruction manual" of every cell. It is damaged tens of thousands of times a day; the cell repairs almost everything, but not everything. Uncorrected errors accumulate, like typos that add up each time a manual is copied.
2. Mechanisms and sources
Sources of damage.
- Endogenous: replication errors, spontaneous hydrolysis (depurination, deamination), reactive oxygen species from mitochondrial metabolism, aldehydes, replication/transcription conflicts.
- Exogenous: UV, ionising radiation, tobacco, chemical agents and chemotherapies.
Nature of the accumulated alterations.
- Somatic point mutations: their number grows linearly with age in virtually all normal tissues. Sun-exposed skin already carries thousands of mutations per cell and clones under positive selection for cancer genes (Martincorena 2015, doi:10.1126/science.aaa6806). Single-molecule sequencing (NanoSeq) confirms a steady accumulation, including in cells that do not divide (Abascal 2021, doi:10.1038/s41586-021-03477-4). Neurons also accumulate mutations, faster in neurodegeneration (Lodato 2018, doi:10.1126/science.aao4426).
- Correlation with species longevity: across 16 mammals, the annual somatic mutation rate is inversely proportional to lifespan, so that at the end of life all animals carry a comparable number of mutations (Cagan 2022, doi:10.1038/s41586-022-04618-z). A strong argument for a role of DNA in the pace of aging, but not proof of causality.
- Double-strand breaks and the efficiency of their repair: the sirtuin SIRT6 is more active in long-lived species and improves repair (Tian 2019, doi:10.1016/j.cell.2019.03.043); its overexpression extends the life of male mice (Kanfi 2012, doi:10.1038/nature10815).
- Aneuploidy and chromosomal mosaicism: loss of the Y chromosome in blood (LOY) affects a large share of older men and is associated with increased mortality (Forsberg 2014, doi:10.1038/ng.2966); in mice, it causes cardiac fibrosis and heart failure, which suggests causality (Sano 2022, doi:10.1126/science.abn3100). Mice deficient in BubR1 (spindle checkpoint) age prematurely; its overexpression extends healthspan and lifespan (Baker 2004, doi:10.1038/ng1382; Baker 2012, doi:10.1038/ncb2643).
- Retrotransposons: LINE-1 elements, normally silenced, reactivate in senescent cells and in aged tissues; their cytoplasmic DNA triggers an inflammatory interferon response (De Cecco 2019, doi:10.1038/s41586-018-0784-9; Simon 2019, doi:10.1016/j.cmet.2019.02.014).
- Mitochondrial DNA (mtDNA): more exposed, less protected. "Mutator" mice (POLG polymerase without proofreading function) accumulate mtDNA mutations and age prematurely (Trifunovic 2004, doi:10.1038/nature02517; Kujoth 2005, doi:10.1126/science.1112125). The role of mtDNA mutations in normal aging remains debated (Kauppila 2017, doi:10.1016/j.cmet.2016.09.017).
- Nuclear envelope: lamin A maintains the architecture of the nucleus; its mutated form (progerin) deforms the nucleus and disrupts repair and chromatin organisation (Eriksson 2003, doi:10.1038/nature01629).
Cellular consequences. Unrepaired damage leads to (i) a transmitted mutation, (ii) cell-cycle arrest and senescence, (iii) cell death, or (iv) clonal selection. The persistent DNA damage response (DDR) is a major driver of senescence and inflammation (Schumacher 2021).
3. Symptoms and clinical manifestations
Human progeroid syndromes (monogenic accelerated aging) — the most direct evidence in humans:
- Werner syndrome (WRN gene, repair helicase): grey hair, cataracts, diabetes, atherosclerosis, cancers from age 20-30 (Yu 1996, doi:10.1126/science.272.5259.258).
- Hutchinson-Gilford progeria (LMNA, progerin): accelerated aging in children, death from cardiovascular disease around age 14-15 (Eriksson 2003).
- ERCC1-XPF deficiency (nucleotide excision repair): severe progeria; in mice, these lesions redirect metabolism towards a "survival" mode close to that of caloric restriction (Niedernhofer 2006, doi:10.1038/nature05456). Deleting Ercc1 in immune cells alone is enough to make solid organs age (Yousefzadeh 2021, doi:10.1038/s41586-021-03547-7).
Clonal hematopoiesis of indeterminate potential (CHIP): blood clones carrying mutations (DNMT3A, TET2, ASXL1…) expand in >10 % of people over 70. They increase the risk of blood cancer, overall mortality (Jaiswal 2014, doi:10.1056/NEJMoa1408617) and cardiovascular risk (Jaiswal 2017, doi:10.1056/NEJMoa1701719); in mice, Tet2-deficient macrophages accelerate atherosclerosis through inflammation (IL-1β/NLRP3) (Fuster 2017, doi:10.1126/science.aag1381).
GWAS: age at menopause, a marker of ovarian aging, is strongly associated with variants in DNA repair genes; manipulating them in mice changes the ovarian reserve (Ruth 2021, doi:10.1038/s41586-021-03779-7).
Associated age-related diseases: cancers (the main one), cardiovascular diseases (CHIP, LOY), neurodegeneration (neuronal mutations), ovarian failure, immunosenescence.
4. Interactions with the other hallmarks
| Hallmark (2023 numbering) | Link with genomic instability |
|---|---|
| 2. Telomere attrition | Telomeres are a specialised form of DNA damage that is hard to repair; persistent DDR at telomeres (see file 02). |
| 3. Epigenetic alterations | Break repair redistributes chromatin proteins and erodes epigenetic information (Yang 2023, doi:10.1016/j.cell.2022.12.027); loss of heterochromatin → awakening of LINE-1. |
| 4. Loss of proteostasis | Mutations produce misfolded proteins; some repair proteins depend on chaperones. |
| 6. Deregulated nutrient sensing | Damage represses the GH/IGF-1 axis (survival response) (Niedernhofer 2006); repair consumes NAD+ (PARP) at the expense of sirtuins (Covarrubias 2021, doi:10.1038/s41580-020-00313-x). |
| 7. Mitochondrial dysfunction | mtDNA mutations → failing respiratory chain → more free radicals → more damage (debated vicious circle). |
| 8. Cellular senescence | Persistent DDR is the main trigger of senescence. |
| 9. Stem cell exhaustion | Damage exhausts stem cells or favours their clonal drift (CHIP). |
| 10. Altered intercellular communication | The secretome of damaged/senescent cells alters neighbouring tissues. |
| 11. Chronic inflammation | Cytoplasmic DNA (LINE-1, micronuclei) → cGAS-STING pathway → interferons (De Cecco 2019); CHIP → IL-1β. |
| 12. Dysbiosis | Some bacteria produce genotoxins: colibactin from pks+ E. coli leaves a distinct mutational signature in organoids and in human colorectal cancers (Pleguezuelos-Manzano 2020, doi:10.1038/s41586-020-2080-8). The link with normal aging remains indirect. |
5. Existing or investigational remedies
| Intervention | Target | Level of evidence | Key result | Source |
|---|---|---|---|---|
| Lonafarnib | Inhibits farnesylation of progerin (HGPS) | Approved (FDA 2020, progeria) | Reduced mortality in treated vs untreated children (cohort study) | Gordon 2018, doi:10.1001/jama.2018.3264 |
| Base editing (ABE) of the LMNA mutation | DNA correction | Preclinical (mice) | A single injection corrects the mutation, reduces progerin and doubles median survival | Koblan 2021, doi:10.1038/s41586-020-03086-7 |
| NAD+ precursors (NMN, NR) | Restore NAD+ (PARP, sirtuins, repair) | Solid preclinical; human phase 1-2 trials | Mice: lessening of age-related declines (Mills 2016); humans: NR safe and raises NAD+ (Martens 2018); NMN improves muscle insulin sensitivity in prediabetic women (Yoshino 2021). No demonstrated benefit on DNA repair in humans. | doi:10.1016/j.cmet.2016.09.013; doi:10.1038/s41467-018-03421-7; doi:10.1126/science.abe9985 |
| SIRT6 activation | Double-strand break repair | Preclinical (transgenic mice) | Overexpression: increased longevity in male mice | Kanfi 2012 |
| BubR1 overexpression | Chromosome segregation | Preclinical (mice) | Less aneuploidy and fewer cancers, longer life | Baker 2012 |
| Reverse transcriptase inhibitors (e.g. lamivudine) | Block LINE-1 | Preclinical | Reduced interferon-type inflammation in old mice | De Cecco 2019 |
| Prevention of exposure (UV, tobacco) | Reduce exogenous damage | Established (epidemiology) | Fewer skin and lung cancers | consensus, not specific to aging |
| Targeting CHIP clones / IL-1β | CHIP-related inflammation | Hypothesis; secondary analyses of trials | Exploratory analysis of the CANTOS trial: in carriers of TET2 CHIP, canakinumab (anti-IL-1β) reduces cardiovascular events (HR 0.38; 95 % CI 0.15-0.96), non-significant interaction | Svensson 2022, doi:10.1001/jamacardio.2022.0386 |
Finding: no intervention has been shown in humans to slow the accumulation of somatic mutations. The only clinical successes concern monogenic diseases (progeria).
6. Open questions
- Causality in normal aging: are somatic mutations numerous enough to explain functional decline, or mainly a cancer risk? The mutations/species-longevity parallel (Cagan 2022) does not prove causality.
- Damage vs mutation: is it the persistent lesion (DDR signal, senescence) or the fixed mutation that matters most? Schumacher 2021 leans towards lesions.
- mtDNA: do mutations reach a functional threshold in normal human aging?
- Clonal mosaicism (CHIP, LOY, clones in the oesophagus or skin): causal factor of disease or mere marker? Should it be treated?
- Improving repair without favouring the survival of cancer cells: no validated strategy in humans.
- Biomarkers: how can the damage burden be measured routinely (single-molecule sequencing, LOY, CHIP)?
7. References
- López-Otín C, et al. Hallmarks of aging: an expanding universe. Cell 2023. doi:10.1016/j.cell.2022.11.001
- López-Otín C, et al. The hallmarks of aging. Cell 2013. doi:10.1016/j.cell.2013.05.039
- Schumacher B, et al. The central role of DNA damage in the ageing process. Nature 2021. doi:10.1038/s41586-021-03307-7
- Martincorena I, et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 2015. doi:10.1126/science.aaa6806
- Abascal F, et al. Somatic mutation landscapes at single-molecule resolution. Nature 2021. doi:10.1038/s41586-021-03477-4
- Lodato MA, et al. Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 2018. doi:10.1126/science.aao4426
- Cagan A, et al. Somatic mutation rates scale with lifespan across mammals. Nature 2022. doi:10.1038/s41586-022-04618-z
- Tian X, et al. SIRT6 is responsible for more efficient DNA double-strand break repair in long-lived species. Cell 2019. doi:10.1016/j.cell.2019.03.043
- Kanfi Y, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012. doi:10.1038/nature10815
- Forsberg LA, et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet 2014. doi:10.1038/ng.2966
- Sano S, et al. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality. Science 2022. doi:10.1126/science.abn3100
- Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes. Nat Genet 2004. doi:10.1038/ng1382
- Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol 2012. doi:10.1038/ncb2643
- De Cecco M, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 2019. doi:10.1038/s41586-018-0784-9
- Simon M, et al. LINE1 derepression in aged wild-type and SIRT6-deficient mice drives inflammation. Cell Metab 2019. doi:10.1016/j.cmet.2019.02.014
- Trifunovic A, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004. doi:10.1038/nature02517
- Kujoth GC, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005. doi:10.1126/science.1112125
- Kauppila TES, et al. Mammalian mitochondria and aging: an update. Cell Metab 2017. doi:10.1016/j.cmet.2016.09.017
- Eriksson M, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003. doi:10.1038/nature01629
- Yu CE, et al. Positional cloning of the Werner's syndrome gene. Science 1996. doi:10.1126/science.272.5259.258
- Niedernhofer LJ, et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006. doi:10.1038/nature05456
- Yousefzadeh MJ, et al. An aged immune system drives senescence and ageing of solid organs. Nature 2021. doi:10.1038/s41586-021-03547-7
- Jaiswal S, et al. Age-related clonal hematopoiesis associated with adverse outcomes. NEJM 2014. doi:10.1056/NEJMoa1408617
- Jaiswal S, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. NEJM 2017. doi:10.1056/NEJMoa1701719
- Fuster JJ, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 2017. doi:10.1126/science.aag1381
- Ruth KS, et al. Genetic insights into biological mechanisms governing human ovarian ageing. Nature 2021. doi:10.1038/s41586-021-03779-7
- Yang JH, et al. Loss of epigenetic information as a cause of mammalian aging. Cell 2023. doi:10.1016/j.cell.2022.12.027
- Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 2021. doi:10.1038/s41580-020-00313-x
- Gordon LB, et al. Association of lonafarnib treatment vs no treatment with mortality rate in patients with Hutchinson-Gilford progeria syndrome. JAMA 2018. doi:10.1001/jama.2018.3264
- Koblan LW, et al. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Nature 2021. doi:10.1038/s41586-020-03086-7
- Mills KF, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab 2016. doi:10.1016/j.cmet.2016.09.013
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun 2018. doi:10.1038/s41467-018-03421-7
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 2021. doi:10.1126/science.abe9985
- Pleguezuelos-Manzano C, et al. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli. Nature 2020. doi:10.1038/s41586-020-2080-8
- Svensson EC, et al. TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol 2022. doi:10.1001/jamacardio.2022.0386
DOIs verified via the Crossref API on 2026-10-19.